TriVascular Technologies (TRIV) Misses Q4 EPS by 7c

TriVascular Technologies (NASDAQ: TRIV) reported Q4 EPS of ($0.72), $0.07 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $9.54 million.

For earnings history and earnings-related data on TriVascular Technologies (TRIV) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• DA Davidson Reiterates Buy Rating on Walmart (WMT) Ahead of Earnings